-
1
-
-
84975525035
-
Clinical applications of research on angiogenesis
-
Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 333:1995;1757-1763.
-
(1995)
N Engl J Med
, vol.333
, pp. 1757-1763
-
-
Folkman, J.1
-
2
-
-
0031057204
-
Angiogenesis for revascularization of ischemic tissues
-
Isner J.M. Angiogenesis for revascularization of ischemic tissues. Eur Heart J. 18:1997;1-2.
-
(1997)
Eur Heart J
, vol.18
, pp. 1-2
-
-
Isner, J.M.1
-
3
-
-
0033982580
-
Effect of intracoronary recombinant human vascular endothelial growth factor in myocardial perfusion: Evidence for a dose-dependent effect
-
Hendel R.C., Henry T.D., Rocha-Singh K., Isner J.M., Kereiakes D.J., Giordano F.J., Simons M., Bonow R.O. Effect of intracoronary recombinant human vascular endothelial growth factor in myocardial perfusion evidence for a dose-dependent effect . Circulation. 101:2000;118-121.
-
(2000)
Circulation
, vol.101
, pp. 118-121
-
-
Hendel, R.C.1
Henry, T.D.2
Rocha-Singh, K.3
Isner, J.M.4
Kereiakes, D.J.5
Giordano, F.J.6
Simons, M.7
Bonow, R.O.8
-
4
-
-
0037097035
-
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): A randomized trial
-
Lederman R.J., Mendelsohn F.O., Anderson R.D., Hermiller J.B., Rocha-Singh K., Mendelsohn F.O., Hiatt W.R., Moon T., Whitehouse M.J., Annex B.H. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study) a randomized trial . Lancet. 359:2002;2053-2058.
-
(2002)
Lancet
, vol.359
, pp. 2053-2058
-
-
Lederman, R.J.1
Mendelsohn, F.O.2
Anderson, R.D.3
Hermiller, J.B.4
Rocha-Singh, K.5
Mendelsohn, F.O.6
Hiatt, W.R.7
Moon, T.8
Whitehouse, M.J.9
Annex, B.H.10
-
5
-
-
0037133306
-
Pharmacologic treatment of coronary artery disease with recombinant fibroblast growth factor-2 (rFGF-2): Double-blind, randomized controlled clinical trial
-
Simons M., Annex B.H., Laham R.J., Henry T.D., Dauerman H., Udelson J.E., Gervino E.V., Pike M., Whitehouse M.J., Moon T.E., Chronos N.A. Pharmacologic treatment of coronary artery disease with recombinant fibroblast growth factor-2 (rFGF-2) double-blind, randomized controlled clinical trial . Circulation. 105:2002;788-793.
-
(2002)
Circulation
, vol.105
, pp. 788-793
-
-
Simons, M.1
Annex, B.H.2
Laham, R.J.3
Henry, T.D.4
Dauerman, H.5
Udelson, J.E.6
Gervino, E.V.7
Pike, M.8
Whitehouse, M.J.9
Moon, T.E.10
Chronos, N.A.11
-
6
-
-
0035060498
-
Pitfalls in the measurement of circulating vascular endothelial growth factor
-
Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clinical Chemistry. 47:2001;617-623.
-
(2001)
Clinical Chemistry
, vol.47
, pp. 617-623
-
-
Jelkmann, W.1
-
7
-
-
0344701100
-
Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia
-
Tofukuji M., Metais C., Li J., Franklin A., Simons M., Selke F.W. Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia. Circulation. 98:(suppl):1998;II242-II246.
-
(1998)
Circulation
, vol.98
, Issue.SUPPL.
-
-
Tofukuji, M.1
Metais, C.2
Li, J.3
Franklin, A.4
Simons, M.5
Selke, F.W.6
-
8
-
-
0031966498
-
Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease
-
Webb N.J., Bottomley M.J., Watson C.J., Brenchley P.E. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting implications for measurement of circulating VEGF levels in clinical disease . Clin Sci. 94:1998;395-404.
-
(1998)
Clin Sci
, vol.94
, pp. 395-404
-
-
Webb, N.J.1
Bottomley, M.J.2
Watson, C.J.3
Brenchley, P.E.4
-
9
-
-
0031889548
-
Release of the angiogenic cytokine endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
-
Banks R.E., Forbes M.A., Kinsey S.E., Stanley A., Ingham E., Walters C., Selby P.J. Release of the angiogenic cytokine endothelial growth factor (VEGF) from platelets significance for VEGF measurements and cancer biology . Br J Cancer. 77:1998;956-964.
-
(1998)
Br J Cancer
, vol.77
, pp. 956-964
-
-
Banks, R.E.1
Forbes, M.A.2
Kinsey, S.E.3
Stanley, A.4
Ingham, E.5
Walters, C.6
Selby, P.J.7
-
10
-
-
0033830775
-
Fiber type-specific differential expression of angiogenic factors in response to chronic hindlimb ischemia
-
Cherwek D.H., Hopkins M.B., Thompson M.J., Annex B.H., Taylor D.A. Fiber type-specific differential expression of angiogenic factors in response to chronic hindlimb ischemia. Am J Physiol. 274:2000;H932-H938.
-
(2000)
Am J Physiol
, vol.274
-
-
Cherwek, D.H.1
Hopkins, M.B.2
Thompson, M.J.3
Annex, B.H.4
Taylor, D.A.5
-
11
-
-
0028344109
-
Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
-
Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.-Q., Bunting S., Ferrara N., Symes J.F., Isner J.M. Therapeutic angiogenesis a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model . J Clin Invest. 93:1994;662-670.
-
(1994)
J Clin Invest
, vol.93
, pp. 662-670
-
-
Takeshita, S.1
Zheng, L.P.2
Brogi, E.3
Kearney, M.4
Pu, L.-Q.5
Bunting, S.6
Ferrara, N.7
Symes, J.F.8
Isner, J.M.9
-
12
-
-
15144360878
-
Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: A comparison of angiographic echocardiographic and coronary flow parameters
-
Lopez J.J., Edelman E.R., Stamler A., Hibberd M.G., Prasad P., Caputo R.P., Carrozza J.P., Douglas P.S., Sellke F.W., Simons M. Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia a comparison of angiographic echocardiographic and coronary flow parameters . J Pharm Exp Ther. 282:1997;385-390.
-
(1997)
J Pharm Exp Ther
, vol.282
, pp. 385-390
-
-
Lopez, J.J.1
Edelman, E.R.2
Stamler, A.3
Hibberd, M.G.4
Prasad, P.5
Caputo, R.P.6
Carrozza, J.P.7
Douglas, P.S.8
Sellke, F.W.9
Simons, M.10
-
13
-
-
0031039243
-
The biology of vascular endothelial growth factor
-
Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 18:1997;4-25.
-
(1997)
Endocr Rev
, vol.18
, pp. 4-25
-
-
Ferrara, N.1
Davis-Smyth, T.2
-
14
-
-
0030942264
-
Endogenous basic fibroblast growth factor displaced by heparin from the luminal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall
-
Medalion B., Gideon M., Aingorn H., Miao H.Q., Nagler A., Elami A., Ishai-Michaeli R., Vlodavsky I. Endogenous basic fibroblast growth factor displaced by heparin from the luminal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall. Circulation. 95:1997;1853-1862.
-
(1997)
Circulation
, vol.95
, pp. 1853-1862
-
-
Medalion, B.1
Gideon, M.2
Aingorn, H.3
Miao, H.Q.4
Nagler, A.5
Elami, A.6
Ishai-Michaeli, R.7
Vlodavsky, I.8
-
15
-
-
0031688684
-
In vitro release of vascular endothelial factor during platelet aggregation
-
Maloney J.P., Silliman C.C., Ambruso D.R., Wang J., Tuder R.M., Voelkel N.F. In vitro release of vascular endothelial factor during platelet aggregation. Am J Physiol. 275:1998;H1054-H1061.
-
(1998)
Am J Physiol
, vol.275
-
-
Maloney, J.P.1
Silliman, C.C.2
Ambruso, D.R.3
Wang, J.4
Tuder, R.M.5
Voelkel, N.F.6
|